Finland vs Switzerland: Treatment success rate for patients treated for MDR-TB
Finland
63.0%
in 2022
Switzerland
60.0%
in 2022
Finland rank
118th
Switzerland rank
120th
Treatment success rate for patients treated for MDR-TB over time
- Finland
- Switzerland
How they compare
Finland currently reports 63.0% against 60.0% in Switzerland, a difference of 3.0%.
That makes Finland's figure about 1.1 times Switzerland's.
The two have swapped places 2 times across 5 shared years of data; in 2015 it was Finland ahead.
Finland ranks 118th and Switzerland ranks 120th of 163 countries.
Across the 2 decades both report, Finland averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | Finland | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.2% | 66.5% | 7.2% | Switzerland |
| 2020s | 63.0% | 60.0% | 3.0% | Finland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Finland or Switzerland?
- Finland, at 63.0% against 60.0% in Switzerland as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Finland and Switzerland?
- 3.0%, with Finland ahead.
- How many years of comparable data are there for Finland and Switzerland?
- 5 years are reported by both, from 2015 to 2022.
- How do Finland and Switzerland rank globally for treatment success rate for patients treated for mdr-tb?
- Finland ranks 118th and Switzerland ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.